Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, protects mice against brain cold injury

European Journal of Pharmacology

Volumn 549, Issue 1-3, 2006, Pages 35-40

  Qian, Xiao Dong ^a   Wei, Er Qing ^a   Zhang, Lei ^a   Sheng, Wen Wen ^a   Wang, Meng Ling ^a   Zhang, Wei Ping ^a   Chen, Zhong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Blood brain barrier; Brain oedema; Cold injury; Leukotriene receptor antagonist; Neuroprotection; Pranlukast

Indexed keywords

IMMUNOGLOBULIN G; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MINOCYCLINE; PEPTIDOLEUKOTRIENE; PRANLUKAST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN SIZE; COLD INJURY; CONTROLLED STUDY; DRUG EFFECT; HEMISPHERE; MALE; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SKULL; STATISTICAL SIGNIFICANCE;

ANIMALS; BRAIN; BRAIN EDEMA; BRAIN INJURIES; CELL COUNT; CHROMONES; COLD; COLD TEMPERATURE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXUDATES AND TRANSUDATES; IMMUNOGLOBULIN G; LEUKOTRIENE ANTAGONISTS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED ICR; NEURONS; RECEPTORS, LEUKOTRIENE;

EID: 33748961961     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.07.056     Document Type: Article

References (24)

1. Baba T., Black K.L., Ikezaki K., Chen K.N., and Becker D.P. Intracarotid infusion of leukotriene C4 selectively increases blood-brain barrier permeability after focal ischemia in rats. J. Cereb. Blood Flow Metab. 11 (1991) 638-643
2. Blum D., Chtarto A., Tenenbaum L., Brotchi J., and Levivier M. Clinical potential of minocycline for neurodegenerative disorders. Neurobiol. Dis. 17 (2004) 359-366
3. Bramlett H.M., and Dietrich W.D. Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J. Cereb. Blood Flow Metab. 24 (2004) 133-150
4. Brink C., Dahlen S.E., Drazen J., Evans J.F., Hay D.W., Nicosia S., Serhan C.N., Shimizu T., and Yokomizo T. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol. Rev. 55 (2003) 195-227
5. Ciceri P., Rabuffetti M., Monopoli A., and Nicosia S. Production of leukotrienes in a model of focal cerebral ischaemia in the rat. Br. J. Pharmacol. 133 (2001) 1323-1329
6. Di Gennaro A., Carnini C., Buccellati C., Ballerio R., Zarini S., Fumagalli F., Viappiani S., Librizzi L., Hernandez A., Murphy R.C., Constantin G., De Curtis M., Folco G., and Sala A. Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienes. Faseb J. 18 (2004) 842-844
7. Friedrich D.H., Plesnila N., Eriskat J., Stoffel M., and Baethmann A. Cerebral blood flow and the secondary growth of brain tissue necrosis after trauma. Acta Neurochir., Suppl. 76 (2000) 257-259
8. Mabe H., Nagai H., and Suzuka T. Role of brain tissue leukotriene in brain oedema following cerebral ischaemia: effect of a 5-lipoxygenase inhibitor, AA-861. Neurol. Res. 12 (1990) 165-168
9. Murakami K., Kondo T., Yang G., Chen S.F., Morita-Fujimura Y., and Chan P.H. Cold injury in mice: a model to study mechanisms of brain edema and neuronal apoptosis. Prog. Neurobiol. 57 (1999) 289-299
10. Neuwelt E.A., Barnett P.A., Hellstrom I., Hellstrom K.E., Beaumier P., McCormick C.I., and Weigel R.M. Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruption. Cancer Res. 48 (1988) 4725-4729
11. Rao A.M., Hatcher J.F., Kindy M.S., and Dempsey R.J. Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils. Neurochem. Res. 24 (1999) 1225-1232
12. Robichaud L.J., and Marcoux F.W. Cold injury, blood-brain barrier changes, and leukotriene synthesis: inhibition by phenidone. J. Neurotrauma 7 (1990) 193-206
13. Sanchez Mejia R.O., Ona V.O., Li M., and Friedlander R.M. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 48 (2001) 1393-1399
14. Schmidt-Kastner R., Meller D., Bellander B.M., Stromberg I., Olson L., and Ingvar M. A one-step immunohistochemical method for detection of blood-brain barrier disturbances for immunoglobulins in lesioned rat brain with special reference to false-positive labelling in immunohistochemistry. J. Neurosci. Methods 46 (1993) 121-132
15. Schmued L.C., and Hopkins K.J. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874 (2000) 123-130
16. Schuhmann M.U., Mokhtarzadeh M., Stichtenoth D.O., Skardelly M., Klinge P.M., Gutzki F.M., Samii M., and Brinker T. Temporal profiles of cerebrospinal fluid leukotrienes, brain edema and inflammatory response following experimental brain injury. Neurol. Res. 25 (2003) 481-491
17. Sewell D.L., Nacewicz B., Liu F., Macvilay S., Erdei A., Lambris J.D., Sandor M., and Fabry Z. Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist. J. Neuroimmunol. 155 (2004) 55-63
18. Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., and Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13496-13500
19. Yu G.L., Wei E.Q., Zhang S.H., Xu H.M., Chu L.S., Zhang W.P., Zhang Q., Chen Z., Mei R.H., and Zhao M.H. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice. Pharmacology 73 (2005) 31-40
20. Zeng L.H., Zhang W.P., Wang R.D., Wang P.L., and Wei E.Q. Protective effect of ONO-1078, a leukotriene antagonist, on focal cerebral ischemia in mice. Acta Pharm. Sin. 36 (2001) 148-150
21. Zhang L.H., and Wei E.Q. Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on transient global cerebral ischemia in rats. Acta Pharmacol. Sin. 24 (2003) 1241-1247
22. Zhang W.P., Wei E.Q., Mei R.H., Zhu C.Y., and Zhao M.H. Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats. Acta Pharmacol. Sin. 23 (2002) 871-877
23. Zhang S.H., Wei E.Q., Zhu C.Y., Chen Z., and Zhang S.F. Protective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia induced by endothelin-1 in rats. Acta Pharm. Sin. 39 (2004) 1-4
24. Zhang W.P., Hu H., Zhang L., Ding W., Yao H.T., Chen K.D., Sheng W.W., Chen Z., and Wei E.Q. Expression of cysteinyl leukotriene receptor 1 in human traumatic brain injury and brain tumors. Neurosci. Lett. 363 (2004) 247-251